Scott T. Reents serves as the Executive Vice President and Chief Financial Officer at AbbVie Inc., a global biopharmaceutical company known for its innovative treatments and commitment to advancing healthcare. Reents joined AbbVie in 2013, prior to its separation from Abbott Laboratories, and has played a pivotal role in shaping the company's financial strategy and growth. His expertise in finance and strategic planning has been instrumental in steering AbbVie through its transformation into a leading player in the biopharmaceutical industry. Before joining AbbVie, Reents held various senior financial positions at Abbott Laboratories, where he gained extensive experience in corporate finance, business development, and financial planning. His career at Abbott spanned over two decades, during which he demonstrated a strong ability to manage complex financial operations and drive strategic initiatives. Reents' leadership and strategic vision have been crucial in helping AbbVie navigate the competitive landscape of the biopharmaceutical sector, ensuring sustainable growth and profitability. As CFO, Reents is responsible for overseeing AbbVie's global finance functions, including financial planning and analysis, accounting, tax, treasury, and investor relations. Under his leadership, AbbVie has successfully managed its financial resources to support the development and commercialization of its diverse portfolio of products. Reents' strategic foresight and financial acumen have been key to AbbVie's ability to invest in research and development, pursue strategic acquisitions, and deliver value to shareholders. His contributions have solidified AbbVie's position as a leader in the industry, committed to improving patient outcomes and advancing medical innovation.